ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: BCR-ABL fusion resulted in a surface protein with constitutive tyrosine kinase activity which is one of the main factors in CML leukemogenesis (Russo et al., 2020; O'Dwyer et al., 2002).